Literature DB >> 22913569

Dual influence of spontaneous hypertension on membrane properties and ATP production in heart and kidney mitochondria in rat: effect of captopril and nifedipine, adaptation and dysadaptation.

A Ziegelhöffer1, J Mujkošová, M Ferko, N Vrbjar, T Ravingerová, O Uličná, I Waczulíková, B Ziegelhöffer.   

Abstract

This study deals with changes, induced by hypertension and its treatment, in the function and properties of mitochondria in the heart and kidneys. Male, 16-week-old hypertensive rats were allocated to 3 groups: (i) animals treated daily for 4 weeks with captopril (CAP, 80 mg·(kg body mass)(-1), n = 45), (ii) animals treated with CAP + nifedipine (NIF, 10 mg·kg(-1), n = 45), or (iii) untreated hypertensive controls (n = 96). Wistar rats (n = 96) were used as normotensive controls. Systolic blood pressure (SBP), heart rate (HR), and heart mass / body mass (HW/BW) ratio were measured at the beginning and end of the experiments; measurements for mitochondrial Mg(2+)-ATPase activity, O(2)-consumption (QO(2)), respiratory control index (RCI), ADP/O, oxidative phosphorylation rate (OPR), conjugated diene content (CD), and membrane fluidity (MF) were also taken at different time intervals. In the heart, elevated SBP, HR, and HW/BW accompanied increased QO(2), OPR, and Mg(2+)-ATPase activity, indicating an adaptive response to hypertension-induced increase in the energy demands of the myocardium. Treatments with CAP or with CAP + NIF were very similar in their prevention of increase in SBP, HR, HW/BW, and the rise in OPR (all p < 0.05-0.01). In the kidneys, hypertension induced a drop in OPR; however, antihypertensive therapy aggravated the resulting energy deficiency, whereby treatment with CAP + NIF was more detrimental than treatment with CAP alone. Heart and kidney mitochondria exhibited negligible changes in CD and moderately increased MF, which was more potentiated by treatment with CAP alone than with CAP + NIF.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22913569     DOI: 10.1139/y2012-107

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  3 in total

Review 1.  Mitochondria: a pathogenic paradigm in hypertensive renal disease.

Authors:  Alfonso Eirin; Amir Lerman; Lilach O Lerman
Journal:  Hypertension       Date:  2014-11-17       Impact factor: 10.190

2.  The novel analogue of hirsutine as an anti-hypertension and vasodilatary agent both in vitro and in vivo.

Authors:  Kai Zhu; Su-Na Yang; Fen-Fen Ma; Xian-Feng Gu; Yi-Chun Zhu; Yi-Zhun Zhu
Journal:  PLoS One       Date:  2015-04-24       Impact factor: 3.240

3.  Effect of antihypertensive agents - captopril and nifedipine - on the functional properties of rat heart mitochondria.

Authors:  Ivana Kancirová; Magdaléna Jašová; Iveta Waczulíková; Táňa Ravingerová; Attila Ziegelhöffer; Miroslav Ferko
Journal:  Iran J Basic Med Sci       Date:  2016-06       Impact factor: 2.699

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.